Parkman Healthcare Partners LLC Xeris Biopharma Holdings, Inc. Transaction History
Parkman Healthcare Partners LLC
- $770 Million
- Q1 2025
A detailed history of Parkman Healthcare Partners LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 1,780,454 shares of XERS stock, worth $8.76 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
1,780,454
Previous 578,511
207.76%
Holding current value
$8.76 Million
Previous $1.96 Million
398.42%
% of portfolio
1.27%
Previous 0.29%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
203Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$50.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$39.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$21.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $669M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...